October 11, 2023 – 4:17 pm
Sadly, my wife Rachel became ill in February 2022 and passed away in July, 2022. Very sad for me and our three sons. We were married for 52 years, so there is a big hole in my life and heart. I went on family medical leave in February and then, when it was not clear […]
Dr. Parker has just written an article for OBG Management, a free OB-Gyn journal with the largest number of readers of all the OB-Gyn journals. In this article, Dr. Parker debunks the myths that gynecologists have been taught about myomectomy and the myths that women are often told as the reasons why they should have […]
January 29, 2016 – 11:42 pm
Jeffrey Shuren, M.D., J.D., the Director of the Center for Device and Radiological Health at the Food and Drug Administration, replied to an open letter from the Leiomyoma Morcellation Review Group. You can read the original open letter here, and view Dr. Shuren’s reply in the images below. The Leiomyoma Morcellation Review Group sent the […]
By webmaster
|
Tagged abdominal myomectomy, FDA, fibroid surgery, fibroids, Food and Drug Administration, laparoscopic myomectomy, laparoscopy, leiomyosarcoma, LMS, Morcellation, morcellation and cancer, morcellation risks, morcellator, ovarian cancer, power morcellation, power morcellator
|
December 8, 2015 – 5:00 pm
In November, 2014 the FDA ruled that power morcellation was contra-indicated in “the majority of women” having surgery for uterine fibroids due to the potential risk of spreading occult uterine sarcoma. Although problems with this ruling were immediately apparent, the passage of time has allowed for more clarity on the related medical issues. Prevalence of […]
By webmaster
|
Tagged abdominal myomectomy, FDA, fibroid surgery, fibroids, Food and Drug Administration, laparoscopic myomectomy, laparoscopy, leiomyosarcoma, LMS, Morcellation, morcellation and cancer, morcellation risks, morcellator, no hysterectomy, ovarian cancer, power morcellation, power morcellator
|
Authors: Donnez J, and others Journal: Fertility & Sterility. 2015 Feb;103:519-27 Study From: Brussels, Belgium and 12 other European medical centers Problem: Ulipristal, currently available in Europe and Canada, is an oral medication that blocks the action of progesterone on fibroids and stops heavy bleeding and decreases the size of fibroids. In an earlier study […]
January 12, 2015 – 8:59 am
Overt hypothyroidism is associated with the presence of uterine leiomyoma: a retrospective analysis. Eur J Obstet Gynecol Reprod Biol. 2014 Jun;177:19-22. Authors: Ott J, Kurz C, Braun R, Promberger R, Seemann R, Vytiska-Binstorfer E, Walch K. Study from: Medical University of Vienna, Vienna, Austria. Problem: Few studies have examined the relationship between low thyroid function […]
January 7, 2015 – 10:56 pm
Authors: Quinn, S, Vedelago J, Gedroyc W, Regan L. Journal: Europeam Journal of Obstetrics & Gynecology and Reproductive Biology Study From: London, England Problem: While MRgFUS (also called high intensity focused ultrasound or HIFU) is not new, the results of treatment over the long-term have not been reported in the medical literature. Study: Following treatment […]
August 19, 2014 – 10:01 am
Some people have recently suggested that all women have biopsies of their fibroids before surgery to determine which women have typical fibroids and which women might have a leiomyosarcoma (LMS). There are many problems with this idea. To start, I am going to use the word tumor throughout this post. When we hear” tumor”, most […]
A recent article in the Journal of the American Medical Association (JAMA) reported that the rate of uterine cancer among women having surgical procedures using morcellation was 1 woman out of 368. Since the recent FDA hearing was about morcellation and the risk of finding uterine leiomyosarcoma (LMS), some of the media have misinterpreted this […]
There is a lot of confusing information circulating about morcellation and uterine leiomyosarcoma in the media since the FDA hearing on this issue a few weeks ago. I plan to post my analysis of the information, in segments, over the next week or two. This first post provides commentary about the numbers used in research […]
By webmaster
|
Tagged FDA, fibroids, laparoscopic myomectomy, laparoscopy, LMS, Morcellation, morcellation risks, myomectomy, power morcellation, risk of LMS, risk of Uterine Leiomyosarcoma, robotic myomectomy, uterine leiomyosarcoma
|
Disclaimer: The ideas, procedures and suggestions contained on this web site are not intended as a substitute for consulting with your physician. All matters regarding your health require medical supervision.